In this paper, we summarized the progression of testing methods for ALKpositive NSCLC patients as well as clinicopathological implication, outcome, and necessity of application of TKIs for earlystage ALK-positive NSCLC patients. Here, ALK is linked to non-small cell lung carcinoma.